Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Vulvodynia
NCT00874484Phase 2
Key facts
- Status
- Completed
- Start
- Mar 2009
- Primary completion
- Apr 2011
- Countries
- 1
- Sponsor
- Galilee Medical Center
- Modality
- Recombinant Proteins and Enzymes
- Drugs
- enoxaparin
- Conditions
- vulvodynia
01
Overview
Phase 2, randomised, double-blind trial in vulvodynia comparing Enoxaparin with Placebo (2 arms). Primary endpoint: Vestibular pain at 1 year. Started Mar 2009; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Enoxaparin
Enoxaparin injections
Placebo
Saline injections
03
Who it enrols
Women with vulvodynia.
04
Endpoints
Primary
Vestibular pain
Beyond the preview
Go deeper on NCT00874484.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874484.